- 全部删除
- 您的购物车当前为空
DOTA-cyclo(RGDfK) 是一种和DOTA类螯合剂多肽,由多肽交联剂DOTA和环状多肽RGDFK构成二聚体,优先靶向肿瘤细胞膜上表达的αvβ3整合素受体,可制备放射性核素偶联物(RDC)并用于癌症诊断和治疗。
DOTA-cyclo(RGDfK) 是一种和DOTA类螯合剂多肽,由多肽交联剂DOTA和环状多肽RGDFK构成二聚体,优先靶向肿瘤细胞膜上表达的αvβ3整合素受体,可制备放射性核素偶联物(RDC)并用于癌症诊断和治疗。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 980 | In stock |
DOTA-cyclo(RGDfK) 相关产品
产品描述 | DOTA-cyclo(RGDfK) is a and DOTA-like chelator peptide consisting of a dimer of the peptide cross-linker DOTA and the cyclic peptide RGDFK, which preferentially targets the αvβ3 integrin receptor expressed on tumor cell membranes, allowing for the preparation of radionuclide coupled compounds (RDCs) and their use in cancer diagnostics and therapy. |
分子量 | 990.07 |
分子式 | C43H67N13O14 |
CAS No. | 909024-55-1 |
Smiles | C([C@@H]1C(=O)N[C@@H](CCCCNC(CN2CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC2)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N1)C3=CC=CC=C3 |
密度 | no data available |
存储 | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||
溶解度信息 | DMSO: 20.00 mg/mL (20.20 mM), Sonication and heating are recommended. | |||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||
DMSO
|
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容